Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease.
The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated.
Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.
Official Title
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Quick Facts
Study Start:2014-03-04
Study Completion:2038-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
Neurology and Pain Specialty
Aliso Viejo, California, 92656
United States
University of Colorado
Aurora, Colorado, 80220
United States
St. Mary's Hospital and Medical Center
Grand Junction, Colorado, 81501
United States
University of Florida Shands Hospital
Gainesville, Florida, 32610
United States
Mayo Clinic, Jacksonville
Jacksonville, Florida, 32224
United States
University of Miami Hospital
Miami, Florida, 33136
United States
Tallahassee Neurological Clinic, PA
Tallahassee, Florida, 32308
United States
University of South Florida
Tampa, Florida, 33612
United States
St. Luke Regional Medical Center
Boise, Idaho, 83702
United States
Rush University Medical Center
Chicago, Illinois, 60612
United States
Methodist Hospital of Indianapolis
Indianapolis, Indiana, 46202
United States
Massachusetts General Hospital
Boston, Massachusetts, 02114
United States
St. Louis University Hospital
Saint Louis, Missouri, 63110
United States
Albany Medical College
Albany, New York, 12208
United States
Northwell Health Neuroscience Institute
Great Neck, New York, 11021
United States
University at Buffalo
Williamsville, New York, 14221
United States
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27157
United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195
United States
Ohio State University
Columbus, Ohio, 43210
United States
Vanderbilt University
Nashville, Tennessee, 37232
United States
Houston Methodist Research Institute
Houston, Texas, 77030
United States
University of Texas Health Medical Arts and Research Center
San Antonio, Texas, 78229
United States
Texas Institute for Neurological Disorders
Sherman, Texas, 75092
United States
University of Virginia Medical Center
Charlottesville, Virginia, 22903
United States
Evergreen Health
Kirkland, Washington, 98034
United States
University of Washington Medical Center
Seattle, Washington, 98195
United States
Inland Northwest Research
Spokane, Washington, 99202
United States
Collaborators and Investigators
Sponsor: Boston Scientific Corporation
- Natalie Bloom Lyons, STUDY_DIRECTOR, Boston Scientific Neuromodulation Corporation
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2014-03-04
Study Completion Date2038-12
Study Record Updates
Study Start Date2014-03-04
Study Completion Date2038-12
Terms related to this study
Keywords Provided by Researchers
- Deep brain stimulation
- Parkinson's disease
- Vercise
Additional Relevant MeSH Terms